MK-677, also known as Ibutamoren, is a growth hormone secretagogue, meaning it stimulates the secretion of growth hormone. There is some evidence suggesting that MK-677 can increase levels of growth hormone and insulin-like growth factor 1 (IGF-1), which are critical in growth and development. This has led to speculation and some anecdotal claims that it might increase height, especially in younger individuals whose growth plates have not yet closed.
Scientific Evidence and Height Increase
●Prepubertal Growth: There is some evidence indicating that MK-677 could potentially increase height in prepubertal children. For instance, studies on growth hormone therapy, which MK-677 mimics, have shown positive effects on height in children with growth hormone deficiencies.
●Postpubertal Growth: For adults or postpubertal individuals, the potential for height increase is very limited. Once the growth plates (epiphyseal plates) close after puberty, long bone growth (and thus height increase) ceases. MK-677 would not be able to reopen these plates, so it is unlikely to increase height in adults.
Considerations and Risks
●Side Effects: MK-677 can cause side effects such as increased appetite, edema (fluid retention), joint pain, and potential insulin resistance.
●Legal and Ethical Issues: MK-677 is not approved by the FDA for increasing height or treating growth deficiencies. It is often used in research settings, and its use outside of these settings is not well-regulated.
Conclusion
MK-677 might offer some potential for height increase in prepubertal children, but for adults, it is highly unlikely to have any effect on height due to the closure of growth plates. If considering MK-677 or any growth-related treatment, it is crucial to consult with a healthcare professional to understand the potential benefits and risks, and to ensure any treatment is safe and appropriate for the individual's specific situation.
